ME Therapeutics Holding (XCNQ:METX) EV-to-FCF : -168.61 (As of May. 21, 2024)

ME Therapeutics Holding EV-to-FCF Chart

Competitive Comparison of ME Therapeutics Holding's EV-to-FCF

For the Biotechnology subindustry, ME Therapeutics Holding's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ME Therapeutics Holding's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's EV-to-FCF falls into.

ME Therapeutics Holding EV-to-FCF Calculation

ME Therapeutics Holding's EV-to-FCF for today is calculated as:

ME Therapeutics Holding's current Enterprise Value is C$103.19 Mil.
ME Therapeutics Holding's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ME Therapeutics Holding  (XCNQ:METX) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

ME Therapeutics Holding's PE Ratio for today is calculated as:

ME Therapeutics Holding's share price for today is C$4.11.
ME Therapeutics Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.296.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

ME Therapeutics Holding EV-to-FCF Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description